As of 2024-12-11, the Relative Valuation of Viking Therapeutics Inc (VKTX) is (16.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 47.85 USD, the upside of Viking Therapeutics Inc based on Relative Valuation is -134.7%.
The range of the Relative Valuation is (16.19) - (17.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 25.0x | 18.4x |
| Forward P/E multiples | 12.6x - 19.6x | 18.9x |
| Fair Price | (16.19) - (17.42) | (16.59) |
| Upside | -133.8% - -136.4% | -134.7% |
| Date | P/E |
| 2024-12-09 | -56.59 |
| 2024-12-06 | -57.10 |
| 2024-12-05 | -56.06 |
| 2024-12-04 | -57.59 |
| 2024-12-03 | -56.49 |
| 2024-12-02 | -57.89 |
| 2024-11-29 | -59.50 |
| 2024-11-27 | -61.27 |
| 2024-11-26 | -60.04 |
| 2024-11-25 | -58.43 |
| 2024-11-22 | -59.11 |
| 2024-11-21 | -58.03 |
| 2024-11-20 | -57.92 |
| 2024-11-19 | -57.89 |
| 2024-11-18 | -55.20 |
| 2024-11-15 | -55.73 |
| 2024-11-14 | -60.21 |
| 2024-11-13 | -61.88 |
| 2024-11-12 | -68.11 |
| 2024-11-11 | -70.77 |
| 2024-11-08 | -76.97 |
| 2024-11-07 | -77.38 |
| 2024-11-06 | -74.03 |
| 2024-11-05 | -72.64 |
| 2024-11-04 | -70.97 |
| 2024-11-01 | -81.91 |
| 2024-10-31 | -81.53 |
| 2024-10-30 | -80.64 |
| 2024-10-29 | -82.44 |
| 2024-10-28 | -83.76 |
| 2024-10-25 | -87.70 |
| 2024-10-24 | -82.30 |
| 2024-10-23 | -67.87 |
| 2024-10-22 | -69.72 |
| 2024-10-21 | -72.31 |
| 2024-10-18 | -73.96 |
| 2024-10-17 | -72.62 |
| 2024-10-16 | -74.01 |
| 2024-10-15 | -73.48 |
| 2024-10-14 | -73.96 |
| 2024-10-11 | -74.00 |
| 2024-10-10 | -70.19 |
| 2024-10-09 | -70.40 |
| 2024-10-08 | -74.94 |
| 2024-10-07 | -70.82 |
| 2024-10-04 | -73.01 |
| 2024-10-03 | -72.06 |
| 2024-10-02 | -72.71 |
| 2024-10-01 | -69.68 |
| 2024-09-30 | -71.16 |